Tackling the high price of prescriptions drugs in the U.S. is still “an absolute priority,” Health and Human Services Secretary Tom Price told senators Thursday.
Pharmaceutical companies have been the target of President Donald Trump ever since he said they were “getting away with murder” in January. While he has threatened on several occasions to force them to bid for government business as a way to reduce prices, he hasn’t translated the threat into action.
For instance, he didn’t include any drug pricing proposals in his recent budget request, a document usually seen as a list of priorities for an administration.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
